Baudax Bio Inc.

NASDAQ: BXRX · Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM

Baudax Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.26M 15.89M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
854K 963K
Receivables
335K 542K
Inventory
n/a 5M
Other Current Assets
753K 2.06M
Total Current Assets
6.35M 23.49M
Property-Plant & Equipment
704K 5.01M
Goodwill & Intangibles
2.13M 23.8M
Total Long-Term Assets
3.69M 29.78M
Total Assets
10.03M 53.28M
Account Payables
3.93M 1.47M
Deferred Revenue
n/a 5.54M
Short-Term Debt
5.6M 2.22M
Other Current Liabilities
11.93M 11.96M
Total Current Liabilities
21.46M 15.65M
Long-Term Debt
1.52M 6.31M
Other Long-Term Liabilities
11.29M 18.1M
Total Long-Term Liabilities
12.81M 24.41M
Total Liabilities
34.27M 40.05M
Total Debt
7.12M 8.53M
Common Stock
16K 983K
Retained Earnings
-190.9M -132.09M
Comprehensive Income
n/a n/a
Shareholders Equity
-24.24M 13.23M
Total Investments
n/a n/a